Updated Canadian recommendations on the use of pneumococcal vaccines in adultsNACI issues new guidance on use of pneumococcal vaccines, incorporating the new 21-valent pneumococcal conjugate vaccine (Capvaxive). What’s new in vaccines?Given this rapid pace of growth, it can be challenging to keep current. This article offers an overview of vaccines recently approved and/or marketed in Canada to help make sense of all these recent changes. Strategies to deal with avian flu: Will Canada start vaccinating poultry? Experts at the Canadian Immunization Conference discussed Canada’s plans to prevent a pandemic. RSV immunization program roll-out in Ontario: The story so far Delivery of RSV immunization by family doctors better than expected. What’s the number needed to vaccinate to keep older adults out of long-term care? Data provides new way to frame discussions about influenza vaccines with older adults. POP QUIZ: Chikungunya vaccine Ixchiq, the first chikungunya vaccine, is now available in Canada. Which statement about Ixchiq is FALSE? New product: Nuvaxovid Get the info you need on this new product, part of our drug news roundup for December. New product: Comirnaty Get the info you need on this new product, part of our drug news roundup for December. New product: Ixchiq: first chikungunya vaccine Get the info you need on this new product, part of our drug news roundup for December. Co-administration of COVID-19 and flu vaccine fine in autoimmune population Data presented at Canadian Immunization Conference show no increased risk of health events. 1 2 3 4 5 Next Last